secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2022-05-19T23:59:59+00:00
Accession:  0001104659-22-062946
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco shareholders approve ESPP, eliminate supermajority voting; director elected despite majority against
--------------------------------------------------------------------------------

- Shareholders approved elimination of supermajority vote to remove directors, replaced with majority vote.
- Approved Employee Stock Purchase Plan reserving 625,000 shares for employees.
- Charter amendments to remove legacy parent provisions passed with 99.98% votes in favor.
- Director Kapila Kapur Anand elected despite 50.1% against votes; other nominees received >86% support.
- All six proposals passed at May 18, 2022 annual meeting; Ernst & Young ratified as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465922062946/0001104659-22-062946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465922062946/tm2215951d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-062946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer